No abstract available.
Female ; Ovulation Induction* ; Ovulation*

No abstract available.
Female ; Ovulation*

No abstract available.
Female ; Ovulation*

No abstract available.
Female ; Ovarian Hyperstimulation Syndrome* ; Ovulation Induction* ; Ovulation*

No abstract available.
Calcium* ; Estrogens* ; Female ; Metabolism* ; Ovulation Induction* ; Ovulation*

No abstract available.
Female ; Growth Hormone* ; Ovulation Induction* ; Ovulation*

No abstract available.
Female ; Mammals* ; Ovulation*

The authors studied on 242 infertile cases due to an ovulation in 296 cycles of treatment by FSH-HCG from 1995 to 1997. The pregnancy rate is 28,51% of cases and 23,31% of cycles. The rate of spontaneous abortion plus embryos death in utero is high 52,7%. The rate of ovarian hyperstimulation is 8,45%. The monitoring of ovarian function by ultrasound and serum estradiol level is very important to prevent the risk of severe hyperstimulation. It is difficult to decrease the rate of abortion and embryo death in utero
Ovulation Induction ; Abortion, Spontaneous

The authors studied in two years on 296 cycles of induced ovulation. The ovarian hyperstimulation syndrome (OHSS) was occurred in 14, 19% of total cycles, in which there are 4,05% of severe OHSS. The rate of pregnancy is 41% of OHSS, instead of 30% of induced ovulation cycles with HMG-HCG. The prevention of OHSS is strictly controlled basing on the monitoring of the function of ovary when induced ovulation with HMG-HCG by serum E2 analysis and follicle diameter measurement with sonography. The HCG after HMG is eliminated when appeared OHSS odd degree I is occurred; and the infusion of serum in case of OHSS of degree III could interrupt the progress of more severe OHSS, and bring the patient to the normal situation.
Ovarian Hyperstimulation Syndrome ; Ovulation

Endometrial biopsy at the second phase of the menstrual cycle for long time is a classical and obvious method for detecting ovulation. But for irregularly menstruated women and those submitted to second phase it may not be performed. Since 1974, the authors had indicated endometrial biopsy at the beginning of the menstrual period and found that this timing of biopsy is reliable. By this work, the authors reported the results of 447 cases of endometrial biopsy performed from December 1995 to June 1998. They concluded that the curettage biopsy at beginning of the menstrual cycle was more advantageous than the conventional curettage biopsy at the second phase, in respect to: easier curettage, lower failure rate (only 1.3%), no infectious accidents and its indication expanded to women with irregular menstruation or to control the results of artificial ovulation from the previous menstrual cycle. Currently, at the Institute for Protection of Mother and Newborn, almost of the endometrial biopsies were performed at the beginning of the cycle. The rate of curettage at the second half of the cycle was only 3.3%. At many other gynecologic units this indication has been widely applied to diagnose ovulation.
Biopsy ; Endometrium ; Ovulation